DLBCL and Follicular Lymphoma Clinical Trials at MD Anderson
![DLBCL and Follicular Lymphoma Clinical Trials at MD Anderson image](https://healthtree.org/images-resize?width=1000&height=1000&imageUrl=https%253A%252F%252Ffirebasestorage.googleapis.com%252Fv0%252Fb%252Fhealthtree-production.appspot.com%252Fo%252Fgallery%25252Fpublic%25252FBetal%252520Oran_6073ec1a-dbbd-40df-a5ee-1b041efb1e84.jpeg%253Falt%253Dmedia)
DLBCL and Follicular Lymphoma Clinical Trials at MD Anderson
Event Description
Dr. Strati, a lymphoma specialist from MD Anderson, joins HealthTree to discuss the recent DLBCL and follicular lymphoma trials he has been working on. This Podcast episode will include the discussion of the completed phase I study of evorpacept and R2 in relapsed indolent B-NHL, the completed phase 2 study of acalabrutinib and R2 in previously untreated indolent B-NHL, the ongoing phase 2 study of loncastuximab as consolidation after CART in DLBCL, and the upcoming phase 2 study of emapalaumab for the treatment of persistent severe cytopenia after CART in DLBCL. Join us to hear the exciting updates on these trials and how you can participate.
Schedule & Agenda
Speakers & Moderators
![The panelist Dr. Paolo Strati](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FScreenshot%202024-03-08%20at%2012.09.01%E2%80%AFPM_fa78015b-4b74-4be3-83eb-a29e4fa44e90.png?alt=media)
Dr. Strati is an Assistant Professor in the Department of Lymphoma and Myeloma and in the Department of Translational Molecular Pathology at MD Anderson Cancer Center, in Houston, TX. He is also the Clinical Director for the Lymphoma Tissue Bank. Dr. Strati earned his medical degree cum laude from the San Raffaele University of Milan (Italy) in 2008, and completed an Internal Medicine Residency at the same institution and, subsequently, at the Mayo Clinic, in Rochester (MN). He also completed a Hematology-Oncology Fellowship at MD Anderson Cancer Center, a Leukemia and Lymphoma fellowship at the same institution, and a Malignant Hematology fellowship at the Barts Cancer Institute, in London (UK). Dr. Strati is committed to gain further insight into the biology of the lymphoma immune microenvironment, and to manipulate its components in order to develop novel effective therapies and to decrease the toxicity of treatment strategies already available for patients with B-cell lymphoma.
![The panelist Kat Richardson](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FKat_205dcbf3-d19c-4c3b-88b0-8f8b1d620abe.jpeg?alt=media)
Kat is from Lehi, Utah and is the Health Education Manager for lymphoma. She has worked in healthcare for a decade now, and earned her degree in Community Health Education and Promotion. Kat is passionate about disease prevention as well as improving quality of life and health equity. She enjoys reading, hiking, baking, ice skating, gardening, time with her family and friends, and most of all, spoiling her nieces and nephew.
Have Any Questions?
Thank you for your interest in the event. If you have any questions, we would love to help!
Feel free to give us a call or send us a message below.
Get In Touch With Us
1-800-709-1113
Support@healthtree.org
![newsletter icon](https://static.healthtree.org/icons/newsletter-icon.png)
Get the latest thought leadership on your Diffuse Large B Cell Lymphoma delivered straight to your inbox
Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.
Thanks to our HealthTree Community for Diffuse Large B Cell Lymphoma Sponsors:
![Regeneron](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FRegeneron_logo_(2).svg_64899492-87cd-4df9-9d4b-07f9618df890.png?alt=media)
![Bristol Myers Squibb](https://firebasestorage.googleapis.com/v0/b/healthtree-production.appspot.com/o/gallery%2Fpublic%2FBristol%20Myers%20Squibb_f22fa9b6-b205-4828-bea5-d645566d3243.png?alt=media)